14 C "synth to clinic" simplifies development process, says Quotient CEO
5 Minuten
Podcast
Podcaster
Beschreibung
vor 16 Jahren
UK contract services firm Quotient Bioresearch says its
"Synthesis-to-clinic" service for 14 C labelled compounds can
simplify early drug development.
"Synthesis-to-clinic" service for 14 C labelled compounds can
simplify early drug development.
Weitere Episoden
3 Minuten
vor 11 Jahren
3 Minuten
vor 12 Jahren
5 Minuten
vor 12 Jahren
4 Minuten
vor 12 Jahren
7 Minuten
vor 12 Jahren
In Podcasts werben
Kommentare (0)